Related Experiment Video
Updated: Aug 19, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Biosynthesis of prodigiosin by white strains of Serratia marcescens isolated from patients
Abstract:
Serratia marcescens isolated from infected adults generally does not synthesize prodigiosin. Other investigators have reported that most clinical strains form a pigment if furnished with 4-methoxy-2,2'-bipyrrole-5-carboxyaldehyde (MBC), a precursor of prodigiosin. To determine whether the pigment was prodigiosin, we studied 65 white strains of S. marcescens isolated from patients. On the basis of response to MBC, we assigned the strains to one of three classes: class 1 (14 strains), strains remaining white; class 2 (48 strains), strains becoming gray or pink; and class 3 (3 strains), strains becoming blue. Ethanol extracts of bacteria of classes 2 and 3 did not behave like prodigiosin when acidified or alkalinized, and the pigment spectra were not similar to prodigiosin spectra. If strains of class 3 were furnished with MBC plus 2-methyl-3-amylpyrrole (MAP), the other immediate precursor of prodigiosin, the pigment synthesized was characteristic of prodigiosin. Strains of classes 1 and 2 responded identically to MBC plus MAP and MBC alone. Although the majority of S. marcescens white strains from patients formed pigments in the presence of MBC, the pigments were not prodigiosin. A few strains did synthesize prodigiosin, but only if furnished with both MBC and MAP.
Insights
Most clinical Serratia marcescens strains do not produce prodigiosin pigment. Supplementation with precursors like 4-methoxy-2,2'-bipyrrole-5-carboxyaldehyde (MBC) and 2-methyl-3-amylpyrrole (MAP) revealed that only a few strains synthesize true prodigiosin.
Area of Science:
- Microbiology
- Biochemistry
Background:
- Serratia marcescens is an opportunistic pathogen.
- Clinical isolates of S. marcescens typically do not produce prodigiosin, a red pigment.
Purpose of the Study:
- To investigate pigment production in white S. marcescens strains from patients.
- To determine if MBC supplementation induces prodigiosin synthesis.
Main Methods:
- Studied 65 white S. marcescens strains from patients.
- Classified strains based on pigment response to 4-methoxy-2,2'-bipyrrole-5-carboxyaldehyde (MBC).
- Analyzed synthesized pigments using acid-base treatments and spectral analysis; tested response to MBC plus 2-methyl-3-amylpyrrole (MAP).
Main Results:
- Most strains (class 1 & 2) produced non-prodigiosin pigments or no pigment with MBC alone.
- Class 3 strains produced blue pigments with MBC.
- Only class 3 strains synthesized characteristic prodigiosin when supplied with both MBC and MAP.
Conclusions:
- Pigments formed by most S. marcescens clinical isolates in response to MBC are not prodigiosin.
- Prodigiosin synthesis in these strains requires both MBC and MAP precursors.
Related Concept Videos
Biosynthesis in Bacteria
Production of Antibiotics
Production of Pharmaceuticals
Production of Biopesticides

